Feb 11 (Reuters) - Australian Competition & Consumer Commission:
- ACCC WILL NOT OPPOSE PROPOSED ACQUISITION OF AUSTRALIAN PHARMACEUTICAL INDUSTRIES BY WESFARMERS
- REVIEW PRIMARILY FOCUSED ON MARKETS FOR RETAIL SALE OF OVER--COUNTER PHARMACEUTICAL AND BEAUTY & PERSONAL CARE PRODUCTS
- INVESTIGATION SHOWED THAT THERE ARE MANY LARGE AND WELL-ESTABLISHED RETAILERS THAT WILL COMPETE STRONGLY WITH WESFARMERS
- API’S COMPETITORS WILL CONTINUE TO COMPETE STRONGLY WITH WESFARMERS AFTER THE ACQUISITION
- ALSO CONSIDERED POTENTIAL EFFECTS ON COMPETITION OF WESFARMERS OWNING BOTH PRICELINE SISTER CLUB AND 50 PER CENT OF FLYBUYS
- ACCC MAINTAINED THAT PROPOSED ACQUISITION WOULD NOT HAVE EFFECT OR LIKELY EFFECT OF SUBSTANTIALLY LESSENING COMPETITION
News: API ACCC Says It Will Not Oppose Proposed Acquisition Of API By Wesfarmers
Add to My Watchlist
What is My Watchlist?